Karyopharm Therapeutics (KPTI) Exchange Rate Effect (2015 - 2025)
Karyopharm Therapeutics (KPTI) reported Exchange Rate Effect of $5000.0 for Q4 2025, up 125.0% on a YoY basis from $2222.2 in Q4 2024, and up 150.0% quarter-over-quarter from $2000.0 in Q3 2025.
Karyopharm Therapeutics (KPTI) Exchange Rate Effect (2015 - 2025) Analysis & Trends
Karyopharm Therapeutics has reported Exchange Rate Effect for 11 years, with the latest figure at $5000.0 in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect rose 125.0% year-over-year to $5000.0; the trailing twelve-month figure through Dec 2025 stood at $20000.0 (up 281.82% YoY), and the FY2025 full-year result was $20000.0, up 281.82% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $5000.0, up from $2000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $242000.0 in Q3 2021, with the low at -$454000.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$28050.0 across 5 years, with a median of -$18000.0 in 2024.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect surged 1323.53% — and 2022, when it plunged 609.38%.
- Karyopharm Therapeutics' Exchange Rate Effect stood at -$135000.0 in 2021, then surged by 193.33% to $126000.0 in 2022, then decreased by 29.37% to $89000.0 in 2023, then sank by 122.47% to -$20000.0 in 2024, then soared by 125.0% to $5000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $5000.0 (Q4 2025), $2000.0 (Q3 2025), and $8000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Karyopharm Therapeutics | 95.31 Mn | 31.56 Mn | 32.74 Mn | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | -20,000.00 |
| Dec 31, 2024 | -20,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -16,000.00 |
| Mar 31, 2024 | -16,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Sep 30, 2023 | -52,000.00 |
| Sep 30, 2023 | -52,000.00 |